MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Income Statement
TSX:MDP - CA58410Q2036 - Common Stock
3.05 CAD
-0.06 (-1.93%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 105.66M | 108.33M | 113.05M | 108.10M | 76.70M | |||
| Cost Of Goods | 50.14M | 51.75M | 53.54M | 48.06M | 38.77M | |||
| Gross Profit | 55.52M | 56.58M | 59.51M | 60.04M | 37.93M | |||
| Operating Expenses | 47.08M | 44.66M | 46.73M | 51.55M | 50.30M | |||
| Research and Development | 1.82M | 1.23M | 1.61M | 2.94M | 5.87M | |||
| Selling, General, and Administrative Expenses | 45.00M | 43.18M | 44.87M | 48.25M | 44.03M | |||
| Operating Income | 8.44M | 11.92M | 12.79M | 8.49M | -12.38M | |||
| Interest Income/Expense | -5.35M | -6.78M | -10.69M | -12.65M | 11.18M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 8.56M | |||
| Non Recurring Items | -3.34M | -3.70M | -1.99M | -875.00K | -2.62M | |||
| Income Before Taxes | 155.00K | 1.44M | 106.00K | -5.04M | -3.82M | |||
| Income Tax | -651.00K | -807.00K | 320.00K | -6.26M | -941.00K | |||
| Net Income | 806.00K | 2.25M | -214.00K | 1.22M | -2.88M | |||
| EBITDA | 16.64M | 19.10M | 18.59M | 14.57M | -6.23M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.03 | 0.08 | -0.01 | 0.06 | -0.15 | |||
| Non GAAP EPS | 0.02 | 0.08 | -0.01 | -0.05 | -1.27 | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.55% | 52.23% | 52.64% | 55.54% | 49.45% | |||
| Profit Margin | 0.76% | 2.07% | -0.19% | 1.13% | -3.75% | |||
| Operating Profit Margin | 7.99% | 11.00% | 11.31% | 7.85% | -16.14% | |||
All data in USD